Human pegivirus -1 (HPgV-1) RNA frequency and genotype distribution in pediatric oncology patients with febrile neutropenia

Anielly Sarana da Silva,Gabriel Montenegro de Campos,Gabriela Marengone Altizani,Alice Chagas Barros,Dennis Maletich Junqueira,Simone Kashima,Sandra Coccuzzo Sampaio,Maria Carolina Elias,Marta Giovanetti,Carlos Alberto Scrideli,Svetoslav Nanev Slavov
DOI: https://doi.org/10.1016/j.virusres.2024.199479
2024-10-10
Abstract:Human Pegivirus-1, typically regarded as a commensal virus, exhibits high prevalence in humans. Its frequency and impact on oncologic pediatric patients with febrile neutropenia (FN), a frequent chemotherapy complication, remains unexplored. In this study, we assessed HPgV-1 RNA prevalence in pediatric patients experiencing FN. Blood samples were collected from 30 children, 15 presenting FN and 15 comprising a control group of either undergoing treatment or in remission. Overall, HPgV-1 RNA was detected in 23.3 % of samples (26.7 % among FN patients and 20.0 % among those under treatment or in remission). Phylogenetic analysis unveiled HPgV-1 genotype 2 predominance among these samples, the most prevalent strain circulating in Brazil. Our findings prompt crucial inquiries into the role of HPgV-1 RNA in FN: is it an incidental finding and if it can influences this clinical entity? Further investigation is imperative to elucidate HPgV-1 implications in vulnerable patients cohorts, potentially informing new approaches and understanding viral dynamics in immunocompromised populations.
What problem does this paper attempt to address?